Non-tuberculous mycobacteria (NTM) are increasingly isolated from CF patients. We carried out a retrospective review of respiratory specimens from paediatric patients at a regional CF centre to assess the possible significance of NTM. Samples from 158 patients were reviewed. 7 patients (4%) were identified as having NTM isolated from at least one clinical specimen (4 male, 3 female, age range when NTM first isolated 7−12 yrs). The sample type of first isolation was a bronchoalveolar lavage (BAL) in 2 cases, sputum in 3 cases and cough swab in 2 cases. The NTM isolated were M avium complex (MAC) (n = 3), M. chelonae (n = 3) and M abscessus (n = 1). Initial NTM positive samples were isolated from 1 patient in 2007, 3 patients in 2008, 2 in 2009 and 1 in 2010. None of the initial positive samples (BALs or sputums) were smear positive, although one patient with an initial smear negative, culture positive sputum was smear positive on a follow-up BAL. All isolates were initially sensitive in vitro to azithromycin and clarithromycin. Only one patient was treated for NTM infection. MAC was isolated from a BAL following deterioration in respiratory symptoms; Burkholderia vietnamiensis was also isolated and he received dual treatment with ciprofloxacin and azithromycin and was showing an improvement in respiratory function at 3 months. All patients had other potential pathogens isolated with NTM, including Aspergillus sp. (n = 4). Three patients received steroids for treatment of ABPA prior to isolation of NTM. Identifying whether NTM represents colonisation or infection is difficult and may be complicated by other organisms; trial of therapy with assessment of response may be indicated. Introduction and Aims: CF and non-CF bronchiectasis are characterised by chronic lung infection and subsequent decline in function. Areas of low oxygen tension have been identified within the lungs of these patients and anaerobes have been isolated with Prevotella spp. predominating. Prevotella spp. are well characterised oral pathogens, and are also suspected of involvement in pulmonary infection. This study aimed to examine the molecular epidemiology of Prevotella spp. Methods: Isolates were cultured under strict anaerobic conditions from CF sputum (n = 5), oral plaque (n = 5), non-CF sputum (n = 4) and a type strain was acquired from the American Type Culture Collection [ATCC (n = 1)]. All isolates were identified by 16s rDNA sequencing and then characterised by PFGE, using XbaI.
Non-tuberculous mycobacteria (NTM) are increasingly isolated from CF patients. We carried out a retrospective review of respiratory specimens from paediatric patients at a regional CF centre to assess the possible significance of NTM. Samples from 158 patients were reviewed. 7 patients (4%) were identified as having NTM isolated from at least one clinical specimen (4 male, 3 female, age range when NTM first isolated 7−12 yrs). The sample type of first isolation was a bronchoalveolar lavage (BAL) in 2 cases, sputum in 3 cases and cough swab in 2 cases. The NTM isolated were M avium complex (MAC) (n = 3), M. chelonae (n = 3) and M abscessus (n = 1). Initial NTM positive samples were isolated from 1 patient in 2007, 3 patients in 2008, 2 in 2009 and 1 in 2010. None of the initial positive samples (BALs or sputums) were smear positive, although one patient with an initial smear negative, culture positive sputum was smear positive on a follow-up BAL. All isolates were initially sensitive in vitro to azithromycin and clarithromycin. Only one patient was treated for NTM infection. MAC was isolated from a BAL following deterioration in respiratory symptoms; Burkholderia vietnamiensis was also isolated and he received dual treatment with ciprofloxacin and azithromycin and was showing an improvement in respiratory function at 3 months. All patients had other potential pathogens isolated with NTM, including Aspergillus sp. (n = 4). Three patients received steroids for treatment of ABPA prior to isolation of NTM. Identifying whether NTM represents colonisation or infection is difficult and may be complicated by other organisms; trial of therapy with assessment of response may be indicated. Results: A total of 29 bronchoscopies were undertaken. Ten procedures in 8 patients were as a direct result of HRCT appearance. In five, BAL identified a significant pathogen which had not been isolated from sputum. In six procedures, no 'atypical organism' was identified. Only one patient had their treatment changed following BAL although results were used to confirm diagnosis and continued treatment. The remaining cases had commenced appropriate therapy pre-bronchoscopy guided by sputum microbiology, past medical history and clinical presentation. Conclusion: Nodular changes on HRCT are not always due to atypical infection. While the majority of patients had been started on appropriate treatment, BAL was useful in guiding long term management.
